ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Toxicity complications from chemotherapy in lung cancer treatment

Dr G.S. Bhattacharyya - FORTIS Hospitals, Kolkata, India
Toxicity complications from chemotherapy in lung cancer treatment ( Dr G.S. Bhattacharyya - FORTIS Hospitals, Kolkata, India )
5 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013

Prevention of colorectal and lung cancer subtypes with aspirin

Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy
Prevention of colorectal and lung cancer subtypes with aspirin ( Dr Andrea De Censi - E.O. Ospedali Galliera, Genova, Italy )
27 Nov 2013

Contribution of the Peruvian Commission against tobacco (COLAT PERU)

Dr Luis Pinillos - National Institute of Neoplastic Diseases (INEM), Lima, Peru
Contribution of the Peruvian Commission against tobacco (COLAT PERU) ( Dr Luis Pinillos - National Institute of Neoplastic Diseases (INEM), Lima, Peru )
22 Nov 2013

Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer

Dr Jonathan Shamash - Barts Cancer Institute, London, UK
Comparing toxicity profiles for 72 hour infusional and conventional bleomycin in testicular cancer ( Dr Jonathan Shamash -  Barts Cancer Institute, London, UK )
15 Nov 2013

UK fight for tobacco control

Prof Linda Bauld - University of Stirling, Stirling, UK
UK fight for tobacco control ( Prof Linda Bauld - University of Stirling, Stirling, UK )
14 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

Editor’s Choice - ecancermedicalscience November 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Editor’s Choice - ecancermedicalscience November 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
14 Nov 2013